We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

MedImaging

Download Mobile App
Recent News Radiography MRI Ultrasound Nuclear Medicine General/Advanced Imaging Imaging IT Industry News

Color-Coded MRI in Development to Make Scans Easier to Read

By MedImaging International staff writers
Posted on 27 Apr 2011
Print article
An engineering researcher is trying to bring color to the black-and-white realm of magnetic resonance imaging (MRI) to make the scans easier to read.

Dr. Li Sun, an associate professor of mechanical engineering in the University of Houston's (UH; TX, USA) Cullen College of Engineering, is working on developing a new class of contrast agents by using iron nanostructures to provide color to MR images for the first time. Dr. Sun recently received a three-year, US$300,000 grant from the US National Science Foundation for MRI research. Original funding came from a seed grant from the Alliance for Nanohealth. Project collaborators include Dr. Dong Liu, an assistant professor of mechanical engineering at UH, and researchers at the University of Texas Health Science Center (San Antonio, USA).

"Currently, MRIs are in black and white. If you use one of the existing contrasting agents, you only adjust the gray scale, which makes the bright parts of the image brighter and the dark parts darker. These new nanostructures will allow you to use different colors to identify each type of tissue," Dr. Sun said.

Most nanostructures are shaped like rods or spheres. Iron nanostructures come in less common shapes, such as dumbbells or tubes, and respond only to a specific magnetic frequency. But unusual shapes are expensive to produce at the necessary nanolevel, prompting Sun to work on a more economical fabrication method for these structures. After these nanostructures are generated, they will be coated in proteins that bond only with certain types of cells, such as those that make up a ligament or a specific internal organ.

In a clinical environment, these new agents will be introduced into a patient, typically in a liquid that will be injected. The patient will then undergo MRI scanning, with the machine programmed to scan at the magnetic frequencies assigned to the different nanostructures injected into the patient. The MRI unit will assign each type of nanostructure it senses a particular color--such as red for a ligament and blue for bone. The scans will be combined into a single, color-coded image.

According to Dr. Sun, creating easier-to-read MRI scans is not the only use for these new nanostructures. Individual cells, such as stem cells, could be tagged with the nanostrucutures and then tracked in the human body. Moreover, nanostructures that bond with cancer cells could be heated with a high-frequency magnetic field, destroying the cancer cells but leaving nearby healthy cells intact, Dr. Sun reported.

"This is high-risk, high-reward research," concluded Dr. Sun. "If we're successful, we'll not only change how much we can learn from an MRI, but impact a lot of other areas of healthcare and research."

Related Links:

University of Houston
University of Texas Health Science Center



NMUS & MSK Ultrasound
InVisus Pro
New
Leg Wraps
Leg Wraps
Digital Radiographic System
OMNERA 300M
Wall Fixtures
MRI SERIES

Print article

Channels

Radiography

view channel
Image: AI can identify “mammographically-visible” types of interval cancers earlier by flagging them at the time of screening (Photo courtesy of ScreenPoint Medical)

AI Improves Early Detection of Interval Breast Cancers

Interval breast cancers, which occur between routine screenings, are easier to treat when detected earlier. Early detection can reduce the need for aggressive treatments and improve the chances of better outcomes.... Read more

Nuclear Medicine

view channel
Image: In vivo imaging of U-87 MG xenograft model with varying mass doses of 89Zr-labeled KLG-3 or isotype control (Photo courtesy of L Gajecki et al.; doi.org/10.2967/jnumed.124.268762)

Novel Radiolabeled Antibody Improves Diagnosis and Treatment of Solid Tumors

Interleukin-13 receptor α-2 (IL13Rα2) is a cell surface receptor commonly found in solid tumors such as glioblastoma, melanoma, and breast cancer. It is minimally expressed in normal tissues, making it... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more